New York University Grossman School of Medicine — New York, New York

New York University Grossman School of Medicine is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University Grossman School of Medicine has participated in 9 clinical trials with 6 currently active.

Therapeutic areas: Hemophilia B, Mucopolysaccharidosis I, Mucopolysaccharidosis II.

Sponsors: Sangamo Therapeutics, BioAegis Therapeutics Inc., BioMarin Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Grossman School of Medicine?

New York University Grossman School of Medicine has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Grossman School of Medicine conducted?

New York University Grossman School of Medicine has 9 clinical trials on record, with 6 currently active. Their work covers Hemophilia B, Mucopolysaccharidosis I, Mucopolysaccharidosis II.

Is New York University Grossman School of Medicine accredited by Crixeo Health?

Yes — New York University Grossman School of Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University Grossman School of Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.